Als Therapy Development Institute

Kyle Denton

Matvey Lukashev

Alan Gill

Fernando G Vieira

Steven N Perrin

Alexei Pushechnikov

Theo Hatzipetros

Peter Demin

The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).

Copper complexes for treatment of neurodegenerative disorders

The present disclosure relates to the use of CuPTSM in methods and compositions for treating subjects with a neurodegenerative disease. Subjects with a neurodegenerative disease can have, e.g., amyotrophic lateral sclerosis (ALS).

Growing community of inventors

Medford, MA, United States of America

Kyle Denton